홈MCP워크벤치Skills
홈워크벤치알림마이페이지
llms.txt · MCP 가이드개인정보처리방침 · 이용약관 · 지원v1.8.3
  1. 홈
  2. /반응

Water → 3-Methyl-7-[2-phenyl-2-(4-ethyl-2,3-dioxopiperazine-1-carboxamido)acetamido]ceph-3-em-4-carboxylic acid

HRID 2296575
인쇄

반응식

HRID 2296575 반응식
[CH3:1][C:2]1[CH2:21][S:20][C@@H:5]2[C@H:6]([NH:9][C:10]([C@H:12]([NH2:19])[C:13]3[CH:14]=[CH:15][CH:16]=[CH:17][CH:18]=3)=[O:11])[C:7](=[O:8])[N:4]2[C:3]=1[C:22]([OH:24])=[O:23].O.C(=O)([O-])[O-].[K+].[K+].[CH2:32]([N:34]1[CH2:39][CH2:38][N:37]([C:40](Cl)=[O:41])[C:36](=[O:43])[C:35]1=[O:44])[CH3:33]>C(OCC)(=O)C>[CH3:1][C:2]1[CH2:21][S:20][C@@H:5]2[CH:6]([NH:9][C:10](=[O:11])[CH:12]([C:13]3[CH:18]=[CH:17][CH:16]=[CH:15][CH:14]=3)[NH:19][C:40]([N:37]3[CH2:38][CH2:39][N:34]([CH2:32][CH3:33])[C:35](=[O:44])[C:36]3=[O:43])=[O:41])[C:7](=[O:8])[N:4]2[C:3]=1[C:22]([OH:24])=[O:23]
참가 물질실험 절차후처리출처 및 근거반응 노트

참가 물질

6

반응물 4

HCID 962WaterHCID 11430Potassium CarbonateHCID 27447CephalexinHCID 1088134-Ethyl-2,3-dioxopiperazinecarbonyl chloride

생성물 1

HCID 705073103-Methyl-7-[2-phenyl-2-(4-ethyl-2,3-dioxopiperazine-1-carboxamido)acetamido]ceph-3-em-4-carboxylic acid수율 55.1%

시약·촉매·용매 1

HCID 8857
Ethyl Acetate
용매
2회

실험 절차

Cephalexin (696 mg., 2 mmoles) was dissolved in 10 ml. of water at 5° C. by the action of potassium carbonate (304 mg., 2.2 mmoles). Ethyl acetate (5 ml.) was added and then 4-ethyl-2,3-dioxopiperazine-1-carbonyl chloride (450 mg., 2.2 mole) was added over a period of 15 minutes at 0°-5° C. After addition was complete, the reaction mixture was stirred for an additional 30 minutes, at which time the ethyl acetate layer was separated and the aqueous phase washed with an additional portion of ethyl acetate. The aqueous phase was adjusted to 2.5 and the product extracted into several portions of fresh ethyl acetate. The acidic ethyl acetate extracts were combined, back-washed with water, washed with brine, dried over anhydrous magnesium sulfate, evaporated to dryness in vacuo, and the residue crystallized from methylene chloride to yield 3-methyl-7-[2-phenyl-2-(4-ethyl-2,3-dioxopiperazine-1-carboxamido)acetamido]ceph-3-em-4-carboxylic acid (568 mg., m.p. 199°-200° C.).

후처리

  1. customat 5° C.
  2. additionAfter addition
  3. customwas separated
  4. washthe aqueous phase washed with an additional portion of ethyl acetate
  5. extractionthe product extracted into several portions of fresh ethyl acetate
  6. washback-washed with water
  7. washwashed with brine
  8. dry with materialdried over anhydrous magnesium sulfate
  9. customevaporated to dryness in vacuo
  10. customthe residue crystallized from methylene chloride

출처 및 근거

ORD 기록
ord-f47efb53f0904d7b8e0960181b74a167
출처 데이터셋
uspto-grants-1984_01
DOI
10.6084/m9.figshare.5104873.v1
특허 번호
US04429128

반응 노트

이 페이지에서참가 물질실험 절차후처리출처 및 근거반응 노트